Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-27

Clinical Trial Update: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

View source ↗

Summary

A completed clinical trial evaluating prognosis of gastric MALT lymphoma after eradication of Helicobacter pylori.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive | Status: COMPLETED